HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Quantitative receptor-based imaging of tumor proliferation with the sigma-2 ligand [(18)F]ISO-1.

Abstract
The sigma-2 receptor is expressed in higher density in proliferating (P) tumor cells versus quiescent (Q) tumor cells, thus providing an attractive target for imaging the proliferative status (i.e., P:Q ratio) of solid tumors. Here we evaluate the utility of the sigma-2 receptor ligand 2-(2-[(18)F]fluoroethoxy)-N-(4-(3,4-dihydro-6,7-dimethoxyisoquinolin-2(1H)-yl)butyl)-5-methyl-benzamide, [(18)F]ISO-1, in two different rodent models of breast cancer. In the first study, small animal Positron Emission Tomography (PET) imaging studies were conducted with [(18)F]ISO-1 and (18)FDG in xenografts of mouse mammary tumor 66 and tracer uptake was correlated with the in vivo P:Q ratio determined by flow cytometric measures of BrdU-labeled tumor cells. The second model utilized a chemically-induced (N-methyl-N-nitrosourea [MNU]) model of rat mammary carcinoma to correlate measures of [(18)F]ISO-1 and FDG uptake with MR-based volumetric measures of tumor growth. In addition, [(18)F]ISO-1 and FDG were used to assess the response of MNU-induced tumors to bexarotene and Vorozole therapy. In the mouse mammary 66 tumors, a strong linear correlation was observed between the [(18)F]ISO-1 tumor: background ratio and the proliferative status (P:Q ratio) of the tumor (R = 0.87). Similarly, measures of [(18)F]ISO-1 uptake in MNU-induced tumors significantly correlated (R = 0.68, P<0.003) with changes in tumor volume between consecutive MR imaging sessions. Our data suggest that PET studies of [(18)F]ISO-1 provide a measure of both the proliferative status and tumor growth rate, which would be valuable in designing an appropriate treatment strategy.
AuthorsKooresh I Shoghi, Jinbin Xu, Yi Su, June He, Douglas Rowland, Ying Yan, Joel R Garbow, Zhude Tu, Lynne A Jones, Ryuji Higashikubo, Kenneth T Wheeler, Ronald A Lubet, Robert H Mach, Ming You
JournalPloS one (PLoS One) Vol. 8 Issue 9 Pg. e74188 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID24073202 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Alkylating Agents
  • Anticarcinogenic Agents
  • Benzamides
  • Ligands
  • Radiopharmaceuticals
  • Receptors, sigma
  • Tetrahydronaphthalenes
  • Triazoles
  • sigma-2 receptor
  • Fluorodeoxyglucose F18
  • vorozole
  • Methylnitrosourea
  • Bexarotene
Topics
  • Alkylating Agents (toxicity)
  • Animals
  • Anticarcinogenic Agents (therapeutic use)
  • Apoptosis (drug effects)
  • Benzamides
  • Bexarotene
  • Blotting, Western
  • Cell Proliferation (drug effects)
  • Female
  • Flow Cytometry
  • Fluorodeoxyglucose F18
  • Humans
  • Image Processing, Computer-Assisted
  • Ligands
  • Mammary Neoplasms, Animal (chemically induced, diagnostic imaging, drug therapy, metabolism)
  • Methylnitrosourea (toxicity)
  • Mice
  • Positron-Emission Tomography
  • Radiopharmaceuticals
  • Rats
  • Receptors, sigma (metabolism)
  • Tetrahydronaphthalenes (therapeutic use)
  • Triazoles (therapeutic use)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: